For example, even in the recent study, four people returned to their original dosing schedule after they began regaining weight
Safety of glucagon-like peptide-1 receptor agonists: a real-world study based on the US FDA adverse event reporting system database
Some individuals get caught in a cycle of not eating due to nausea, which worsens the symptoms and further reduces the likelihood of eating
She didnt think quitting the drugs would be that big of a deal: She had lost as much as she wanted to, and in her mind, the companys messaging throughout her two years had suggested that, unless you were a diabetic, there was no need to stay on the GLP-1. But Isherwood told Fortune that within six to eight months, she gained back about 20 pounds as she reverted to old behaviors when stressors arose in her lifea familiar pattern that shed experienced before
Medicare Part D patients continue to face prior authorization and cost-sharing barriers, even with a diabetes diagnosis 3
20 These are just a few of the many possibilities being explored as we speak
